CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 206 enrolled
Drug / intervention
Problem Solving Treatment +1 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00042211
NCT00042211Phase 3Completed
CompareCT.gov

Preventing Depression in Macular Degeneration

Thomas Jefferson University·interventional·Posted Jul 26, 2002·Updated Jan 8, 2014

In Brief

A Phase 3 clinical trial evaluating Problem Solving Treatment and Control for Depression and Macular Degeneration. Completed, enrolled 206 participants across 1 site.

Detailed Summary

This study will evaluate the effectiveness of a Problem Solving Treatment in preventing depression in elderly patients with age-related macular degeneration (AMD).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDepression, Macular Degeneration
CountriesUnited States
CollaboratorsNational Institute of Mental Health (NIMH)

Timeline

Phase 3CompletedFinished
200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJul 26, 2002
Enrollment StartFeb 1, 2001
Primary CompletionJan 1, 2006
TodayJul 2, 2026
Enrollment to primary: 4.9 yearsPosted 23.9 years ago

Interventions

Problem Solving Treatmentbehavioral

Brief Cognitive Behavioral Therapy

Controlbehavioral

No treatment control